Topical nanoencapsulated cannabidiol cream as an innovative strategy combating UV-A–induced nuclear and mitochondrial DNA injury: A pilot randomized clinical study
Journal of the American Academy of Dermatologyn=19
🔍
At 24 hours, 21% of participants showed less erythema on nCBD-treated skin versus vehicle; nCBD reduced UV-A–induced epidermal hyperplasia (P=.01),...
Key finding